KTA Capital Advises SpringTree Global Investors on an AU$25.5 Million Investment in Prima BioMed Ltd
SpringTree Special Opportunities Fund, LP ("SpringTree") announced today its AU$25,500,000 investment
in Prima BioMed Ltd (ASX:PRR), an Australian Securities Exchange-listed oncology biotechnology company. KTA Capital acted as the exclusive financial advisor to SpringTree's general part...
New RISI Report Analyzes South American Tree Farm and Biomass Energy Investment Opportunities
BEDFORD, Mass., July 14 /PRNewswire/ -- RISI, the leading information provider for the global forest products industry, today announced the publication of the South American Tree Farm Update: Opportunities for Investment
in Forest Industry and Biomass Energy Plantations . This new study upda...
Cord Blood America Secured $7.5 Million Investment For Series A Preferred Stock
SANTA MONICA, Calif., July 7 /PRNewswire-FirstCall/ -- Cord Blood America, Inc. (OTC Bulletin Board: CBAI), one of the largest umbilical cord blood stem cell preservation companies ( http://www.cordblood-america.com ) focused on bringing the life saving potential of stem cells to families nati...
Celtic Pharma Holdings Announces Investment in Novacta Biosystems Limited
ST PETER PORT, Guernsey and LONDON, July 6 /PRNewswire/ --
- GBP13.1 Million Funding to Drive Novel Antibiotics Platform Addressing
Areas of Major Unmet Need, Including Hospital Acquired Infections C.
Difficile and MRSA
Celtic Pharma Holdings Advisors LLP ("CPHA"), the advisor to...
Optimal Reading Services Group, Inc. Receives Investment from Health Evolution Partners Investment
Positions Optimal for Expansion in Medical Imaging Management
For Hospitals, Clinics and Radiology Groups
BIRMINGHAM, Ala., June 4 /PRNewswire/ -- Optimal Reading Services Group, Inc., a US-based, leading provider of medical imaging optimization services for hospitals, imaging c...
Clarient Completes Second Tranche of Private Placement of Convertible Preferred Stock With Oak Investment Partners
$40 Million in Total Proceeds Retire Safeguard Mezzanine Debt Facility; Support Profitable Growth
ALISO VIEJO, Calif., May 18 /PRNewswire-FirstCall/ -- Clarient , Inc. (Nasdaq: CLRT ), a premier anatomic pathology and molecular testing services resource for pathologists, oncologists and ...
Cadence Pharmaceuticals' CEO Ted Schroeder to Present at Two Investment Conferences During the Month of May 2009
SAN DIEGO, May 5 /PRNewswire-FirstCall/ -- Cadence Pharmaceuticals, Inc. (Nasdaq: CADX ), a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary product candidates principally for use in the hospital setting, announced today that the company's President a...
Venture Capital Veteran John Brooks Joins Life Science Investment Bank Johnston Blakely & Company
BOSTON, May 4 /PRNewswire/ -- Johnston Blakely & Company, LLC, a Boston-based life science investment
bank, is pleased to announce that John L. Brooks, III has joined the firm as senior advisor. In this role, Mr. Brooks will participate with the firm on internal and client-related activities ...
Bio-Matrix Scientific Group, Inc. Gets Updated Stock Recommendation By KonLin Investment Letter
SAN DIEGO, March 23 /PRNewswire-FirstCall/ -- Bio-Matrix Scientific Group, Inc. (OTC Bulletin Board: BMSN), a San Diego-based biotechnology company, today announced that it has received an updated stock buy recommendation from the KonLin Letter, a New York-based investment
newsletter ( www.konlin....
InSightec Ltd. Announces US$15 Million Investment Round
TIRAT CARMEL, Israel, March 19 /PRNewswire/ -- InSightec Ltd. reported
today that it has closed an internal round of financing totaling US$15
million from its existing investors.
Elbit Imaging Ltd. (NASDAQ: EMITF ) ("EI") has invested US$7.5M on March
18, 2009. Additional US$7.5M woul...
Oppenheimer Announces the Addition of Several Recent Senior Hires in Investment Banking
NEW YORK, March 17 /PRNewswire/ -- Oppenheimer & Co. Inc., a unit of Oppenheimer Holdings Inc., is pleased to announce the addition of several recent senior hires in the Investment
Brian A. McCarthy has joined the firm as the Head of our Healthcare Investment
Monsanto's Historic R&D Investment has Contributed to Mid-20s Gross Profit Growth for Its Seeds and Genomics Segment
Drought-Tolerance Technology Crosses Another Key Regulatory Milestone
LONDON, March 10 /PRNewswire-FirstCall/ -- Monsanto's historic investment
in research and development in breeding and biotechnology has contributed to a 24 percent compound annual growth rate for the company's Seeds and G...
GlycoVaxyn AG Raises CHF 25 Million in Financing Led by Edmond de Rothschild Investment Partners
SCHLIEREN, Switzerland, March 5 /PRNewswire/ --
- Proceeds to Facilitate Clinical Development of Lead Conjugate Vaccine
GlycoVaxyn, a pioneer in the development of innovative conjugated
vaccines, today announced the successful closing of a CHF25 million (ca.
US$22 million, EUR17 ...
The Pittsburgh Life Sciences Greenhouse Starts 2009 With Investment Momentum
PITTSBURGH, Feb. 17 /PRNewswire/ -- The Pittsburgh Life Sciences Greenhouse (PLSG), the premier life sciences seed and early-stage investor in western Pennsylvania, has surpassed the $13 million mark in committed investments. The PLSG's $13.2 million in direct investments in nearly 60 companies ha...
Chronic Lung Disease - Axentis Pharma Attracts Investment Interest
ZURICH, February 2 /PRNewswire/ -- Axentis Pharma AG is to present its
recent successes in developing and financing a new therapeutic formulation
for treating chronic lung disease at the 2nd Annual European Life Science CEO
Forum in Zurich, Switzerland. This invited talk comes just three weeks...
Advanced Instruments Makes Strategic Investment in Cantimer, Inc.
Companies to Collaborate on Next Generation Laboratory Instruments
MENLO PARK, Calif. and NORWOOD, Mass., Jan. 29 /PRNewswire/ -- Cantimer, Inc. and Advanced Instruments, Inc. today jointly announced that Advanced Instruments Inc. has made a $1 Million equity investment
in Cantimer. The two ...
XTENT to Retain Investment Bank to Pursue Strategic Alternatives
MENLO PARK, Calif., Jan. 23 /PRNewswire-FirstCall/ -- XTENT, Inc. (Nasdaq: XTNT ) today announced that it plans to engage an investment
bank to help the company pursue strategic alternatives which may include the sale of some or all of the company's assets or other types of merger or acquisition...
Progentix Orthobiology and NuVasive Sign Investment Agreement
BILTHOVEN, The Netherlands, January 14 /PRNewswire/ -- Progentix
Orthobiology B.V. announced today that it has closed an investment
with NuVasive, a medical device company focused on developing products for
minimally disruptive surgical treatments for the spine. Under the terms of
Biotechnology Veteran Michael Webb Joins Boston-based Investment Bank as Senior Advisor
BOSTON, Jan. 13 /PRNewswire/ -- Johnston Blakely & Company, LLC, a
Boston-based life science investment
bank, is pleased to announce that Michael
D. Webb has joined the firm as senior advisor. In this role, Mr. Webb will
participate with the firm on internal and client-related activities ...
Houlihan Smith Arranges Non-Control Equity Investment Into Sottera, Inc., dba NJOY, by Miri Pharma, Inc.
CHICAGO and PHOENIX, Jan. 9 /PRNewswire/ -- Houlihan Smith & Co., Inc.
acted as the exclusive advisor in arranging a non-control equity investment
into Sottera, Inc. d/b/a NJOY, as announced by Charles Botchway, Group
Managing Director and Vice Chairman of Houlihan Smith & Company, Inc...
Norton & Associates Inc. Adds $3bnUSD Commercial Real Estate Investment P & L Management Holding Group; US Property Portfolio Inc.
Robert H. Norton, MBA, PE, President of Norton & Associates with Divisions in NORTECH Realty, Investment, and Carbon Technology Management with the Carbon Credit Today. The group's announcement of a new holding corporation, US Property Portfolio, private equity land investments and the acqu...
Health Robotics Announces $60M Investment by Devon International Group and ITOCHU Inc. in the CytoCare(TM) and i.v.Station(TM PENDING) Robots
BOZEN, Italy, November 21 /PRNewswire/ -- Health Robotics today announced
that it has signed a definitive agreement with Devon International Group
(DIG) and its strategic partner ITOCHU International, Inc., whereby DIG and
ITOCHU have acquired the exclusive rights to manufacture, market,
North Carolina's Biotechnology Investment Tops Billion-Dollar Mark; Battelle Study Quantifies Economic Dividends and Jobs
Total impact of NC's biotechnology sector is $45.8 billion, 180,007 jobs
RESEARCH TRIANGLE PARK, N.C., Nov. 20 /PRNewswire-USNewswire/ -- North Carolina has invested more than $1 billion in its expanding biotechnology enterprise during the past 10 years, and the annual economic impact exc...
Genomic Health to Present at Stephens Fall Investment Conference
REDWOOD CITY, Calif., Nov. 11 /PRNewswire-FirstCall/ -- Genomic Health,
Inc. (Nasdaq: GHDX ) today announced that Randy Scott, Ph.D., Genomic
Health's Chairman and Chief Executive Officer, will present at the Stephens
Conference in New York on Tuesday, November 18, 2008 at
South Africa's Minister of Minerals and Energy Welcomes Denham Capital Investment in BioTherm Energy to Develop Power Generation Business
Partnership will help alleviate South African power crisis
JOHANNESBURG, South Africa and BOSTON Nov. 9 /PRNewswire/ -- Denham
Capital, a leading energy-focused global private equity firm, announced
today that it will invest equity of up to R1,5 billion (US $150 million, 95
million pounds St...
New Generation Biofuels CEO to Present at the Rodman & Renshaw Annual Global Investment Conference
LAKE MARY, Fla., Nov. 7 /PRNewswire-FirstCall/ -- New Generation
Biofuels Holdings, Inc. (Nasdaq: NGBF ), a renewable fuels provider, today
announced that David Gillespie, President & CEO, is scheduled to present at
the Rodman & Renshaw Annual Global Investment
Conference on Monday,
Memory Pharmaceuticals to Present at the Rodman & Renshaw Annual Global Investment Conference
MONTVALE, N.J., Nov. 6 /PRNewswire-FirstCall/ -- Memory Pharmaceuticals
Corp. (Nasdaq: MEMY ) today announced that Michael Smith, Chief Financial
Officer and Head of Business Development, will provide a company update at
the Rodman & Renshaw Annual Global Investment
Conference on Tuesday,
AMDL, Inc. New President & CEO Douglas MacLellan to Present at Rodman & Renshaw Annual Global Investment Conference November 12, 2008
TUSTIN, Calif., Nov. 6 /PRNewswire-FirstCall/ -- ( http://www.amdl.com )
AMDL, Inc. (Amex: ADL ), a leading vertically-integrated pharmaceutical
company with major operations in China and the U.S., today announced its
newly appointed Chairman and CEO Mr. Douglas MacLellan will present at
Access Pharmaceuticals to Present at the Rodman & Renshaw Annual Global Investment Conference
DALLAS, Nov. 6 /PRNewswire-FirstCall/ -- Access Pharmaceuticals, Inc.
(OTC Bulletin Board: ACCP) announced today that it will make a presentation
at the Rodman & Renshaw Annual Global Investment
Conference to be held
November 10-12, 2008 at the New York Palace Hotel. Jeffrey B. Davis, CEO of
Anadys Pharmaceuticals to Present at Rodman & Renshaw Annual Global Investment Conference
SAN DIEGO, Nov. 4 /PRNewswire-FirstCall/ -- Anadys Pharmaceuticals,
Inc. (Nasdaq: ANDS ) announced today that it will present at the Rodman &
Renshaw Annual Global Investment
Conference on Tuesday, November 11, 2008
at 11:35 a.m. EST (8:35 a.m. PST) at the New York Palace Hotel.
The Female Health Company to Present at Rodman & Renshaw 10th Annual Global Investment Conference
Presentation Scheduled for November 11, 2008 at 9:55 a.m. EST
CHICAGO, Nov. 4 /PRNewswire-FirstCall/ -- The Female Health Company
(Amex: FHC ) today announced that O.B. Parrish, the Company's Chief
Executive Officer, and Donna Felch, Chief Financial Officer, will present
at the Rodman & ...
Oncothyreon to present at Rodman & Renshaw Annual Global Investment Conference
SEATTLE, Nov. 4 /PRNewswire-FirstCall/ - Oncothyreon Inc. (Nasdaq:
ONTY) (TSX:ONY), a biotechnology company specializing in the development of
innovative therapeutic products for the treatment of cancer, today
announced that Robert Kirkman, M.D., President and Chief Executive Officer,
MannKind to Present at the Rodman & Renshaw Annual Global Investment Conference
VALENCIA, Calif., Nov. 3 /PRNewswire-FirstCall/ -- MannKind Corporation
(Nasdaq: MNKD ), focused on discovering, developing and commercializing
treatments for diabetes and cancer, announced today that it will present at
the Rodman & Renshaw Annual Global Investment
Conference on Monday,
Catalyst Pharmaceutical Partners to Present at the Rodman & Renshaw 10th Annual Global Investment Conference
CORAL GABLES, Fla., Nov. 3 /PRNewswire-FirstCall/ -- Catalyst
Pharmaceutical Partners, Inc. (Nasdaq: CPRX ) a biopharmaceutical company
that acquires or in-licenses, develops and commercializes prescription
drugs for the treatment of drug addiction and obsessive compulsive
disorders, today an...
Tianyin Pharmaceutical Co., Inc. to Present at Rodman & Renshaw Annual Global Investment Conference in New York City on November 11, 2008 at 12:00 p.m. EST
CHENGDU, China, Oct. 27 /Xinhua-PRNewswire-FirstCall/ -- Tianyin
Pharmaceutical, Co., Inc., (Amex: TPI ), a manufacturer and supplier of
modernized traditional Chinese medicine ("TCM") based in Chengdu, China,
today announced that the Company will present at the Rodman & Renshaw
China Yingxia to Present at Rodman & Renshaw Annual Global Investment Conference
HARBIN, China, Oct. 24 /Xinhua-PRNewswire-FirstCall/ -- China Yingxia
International, Inc. (OTC Bulletin Board: CYXI) ("China Yingxia" or "the
Company"), a leading provider in the health and nutritional food industry
engaged in the development, manufacture and distribution of nutritional
AFFiRiS - MIG-Fonds Increases Investment by Euro 3 Million
VIENNA, Austria, September 25 /PRNewswire/ -- The successful progress
of several vaccine programmes run by AFFiRiS GmbH has prompted investor MIG
AG to increase its investment
in the company. It has set up two new funds -
MIG 5 and MIG 7 - to give private investors in Germany and Austria the
U.S. Genomics Inc. Receives $4.5 Million Investment from BD
- Enters Strategic Collaboration for Development of Novel Infectious Disease Diagnostic Platform -
WOBURN, Mass., Sept. 23 /PRNewswire/ -- U.S. Genomics today announced
it has received a $4.5 million equity investment
from BD (Becton, Dickinson
and Company) and that the c...
Gen-Probe to Webcast Presentation at the Bank of America 38th Annual Investment Conference
SAN DIEGO, Sept. 10 /PRNewswire-FirstCall/ -- Gen-Probe Incorporated
(Nasdaq: GPRO ) announced today that the Company will present at the Bank of
America 38th Annual Investment
Conference on Tuesday, September 16, 2008 at
approximately 8 a.m. Pacific Time. The presentation is scheduled to be
Abbott to Present at UBS 'Best of Americas' Investment Conference
ABBOTT PARK, Ill., Sept. 5 /PRNewswire-FirstCall/ -- Abbott (NYSE: ABT )
will present at the UBS "Best of Americas" Investment
Conference on Friday,
Sept. 12, 2008, in London. John B. Thomas, vice president, Investor
Relations, will make a formal presentation on the company at 2 a.m. Central